Groups Feed

Well, that’s it. Today we wrapped up the last of the animals for the year here at Worth the Wait Farm. The turkeys had their turn, and now they’re all processed, packaged, and cooling down, ready to head out the door.

These birds are destined for Thanksgiving tables, and they’ll be waiting for pickup this Sunday afternoon at the farm. That gives folks plenty of time to get them home, brined, and ready for the big meal.

There’s a certain relief that comes with finishing the season. Processing isn’t glamorous work, but it’s honest work. We raise these animals with care, and when the time comes, we do right by them. Sending them off to feed families feels like closing the loop.

So if you’re picking up a turkey this weekend, know it’s the last bird of the year, raised on pasture and finished with respect. We’re grateful for your…

Well folks, we have plucked our last cluck for the year.

The final batch of Jumbo Cornish Cross has ridden off the pasture and made their way into the freezer, officially marking the end of chicken processing season. They were raised on fresh grass, with non-GMO, soy-free feed, and just enough sass to keep things interesting.

This last round was parted out into 59 pounds of skinless, boneless breasts (aka the crowd pleasers), 21.9 pounds of drumsticks (perfect for backyard BBQ dreams), 28.5 pounds of thighs (rich, juicy, and always underrated), 14.1 pounds of wings (split into drumettes and flats for fairness), and 7.2 pounds of ground chicken (because sometimes you just want a burger).

That is 130.7 pounds of pasture-raised goodness, ready to fuel soups, stir-fries, and spontaneous dinner parties until next season rolls around.

Get answers and share knowledge.

Share stories, ideas, pictures and more!

A New Hope: The Transformative Power of CAR T-Cell Therapy in the U.S.

The U.S. healthcare system stands at the global forefront of an extraordinary medical revolution: the rise of CAR T-cell therapy. This groundbreaking form of immunotherapy, which re-engineers a patient's own immune cells to seek out and destroy cancer, is no longer a futuristic concept. It's a rapidly expanding reality, offering a beacon of hope for patients with specific blood cancers who have run out of other treatment options.

The U.S. is the dominant force in the global CAR T-cell therapy market, driven by a combination of factors: an advanced regulatory framework, significant investment in research and development, and a sophisticated healthcare infrastructure. The market, already valued in the billions of dollars, is projected to experience explosive growth in the coming decade.

What is CAR T-Cell Therapy?

CAR T-cell therapy, short for Chimeric Antigen Receptor T-cell therapy, is a highly personalized and complex treatment. The process is a multi-step journey:

1. Collection: A patient's T-cells (a type of…